Item specifics

Condition:
New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is ... Read moreabout the condition
Brand:

Gelert

Number of Sections: 9 MPN:

GEL-HOR6SUP-BLU

Total Length of Pole Run: 472cm approx Tent Model: Horizon 6 Supreme
Type: Tent Repairs Material: Fibreglass Pole Sections
Colour: Blue Coded Diameter: 11mm
Weight: 1kg UPC:

Does Not Apply

ISBN:

Does Not Apply

EAN:

5055478647641

Gelert Horizon 6 Supreme blueee Coded Fibreglass Replacement Tent Pole Run

Nationally Ranked Specialties

Maillot de football retro RCS Anderlecht N°14 2002-2003

Building Update

Building Elevated View

University of Iowa Stead Family Children’s Hospital is designed as a healing environment that improves the health and well-being of children and their families. Plans include expanding existing programs and developing new services on-site and throughout Iowa to meet the current and future needs of Iowa’s children.

8 strand (1 wide) Plaited Front (nose) Show Halter Foal Yrlgs Welsh Cob Lge M&M

News

CMP Functional Pants Hiking Pants Woman Long Pant Grey Windproof

Bowling Ball Urethane 14 Lbs, Houseball Green, Incl. XL Drilling, Bowling Ball

University of Iowa Stead Family Children’s Hospital joins a group of more than 30 sites across the country committed to using research and education to help prevent injury to children.

Pro Hunter Micro Sight .029

Join us on Friday, July 12 at University of Iowa Health Care - Iowa River Landing for a bike safety event geared to the whole family.

Edward Bell receives mentor award from Pediatric Academic Societies

Brine - Lacrosse Clutch Arm Pad Small - NEW

Edward Bell, MD, a neonatologist at University of Iowa Stead Family Children’s Hospital, has been awarded the Maureen Andrew Mentor Award from the Society of Pediatric Research, following his 40 years in pediatric medicine.

UI study suggests new approach to treating kids with relapsed cancer

Obermeyer Double Take Ladies Snow Ski Pants Size 10 color Brown NEW

UI researchers led by Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer.